Life Sciences

New CEO David Cutler buys a million shares of Centric Health

Daniel Carriere (right), seen here with Ontario Premier Dalton McGuinty, stepped down as CEO of Centric Health in April. It’s been a short time on the job for new Centric Health (TSX:CHH) CEO David Cutler, but he’s clearly feeling positive about the new gig.

On September 3rd, Cutler bought a million shares of his new company’s stock in the open market, at $.72 cents.

Cutler took the job late in July, after Daniel Carriere stepped down to pursue other interests. His previous job was with Leisureworld Senior Care, which he joined in 1990 and grew to the position of Canada’s fifth largest operator of senior housing and the third largest licensed long-term-care provider in Ontario. Cutler also serves on the board of the Ontario Nursing Home Association.

Founded in 2001, Toronto-based Centric Health provides a range of healthcare services including rehabilitation management, medical assessments, and physiotherapy. The company has quietly become a player in the Canadian healthcare services field, having grown its revenue from $15.7-million in fiscal 2008 to more than $200-million in 2011. The physiotherapy market has become a focus for Centric. In Q1 alone, the The company expanded its national footprint in the vertical with the acquisition of five physiotherapy businesses.

In Centric Health’s Q2, which was reported August 14th, the company earned $42.2-million on revenue of $114.1-million. Buoyed by more than a half dozen recent acquisitions, the topline number was a 240% increase over the same period a year prior.

____________________

_____________________

Tagged with: chh
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

Tilray price target chopped at Roth Capital

Roth Capital Markets analyst Bill Kirk said in a July 30 note that Tilray’s (Tilray Stock Quote, Chart, News, Analysts,… [Read More]

25 minutes ago

Bitcoin Treasury Corporation is a buy, Research Capital says

Research Capital analyst Greg McLeish initiated coverage of Bitcoin Treasury Corporation (Bitcoin Treasury Corporation Stock Quote, Chart, News, Analysts, Financials… [Read More]

31 minutes ago

Cannara Biotech is a buy, Research Capital says

Research Capital analyst Greg McLeish said in a July 29 update that Cannara Biotech (Cannara Biotech Stock Quote, Chart, News,… [Read More]

23 hours ago

Ahead of Q2 results, is Tantalus Systems a buy?

Beacon Securities analyst Gabriel Leung noted in a July 30 report that Tantalus Systems (Tantalus Systems Holding Stock Quote, Chart,… [Read More]

23 hours ago

Sanuwave Health is a buy, Roth Capital says

Roth Capital Markets is initiating coverage of Sanuwave Health (Sanuwave Health Stock Quote, Chart, News, Analysts, Financials NASDAQ:SNWV) with a… [Read More]

24 hours ago

Shoulder Innovations is an IPO to watch, this analyst says

Roth Capital Markets analyst Jason Wittes noted in a July 28 pre-IPO report that Shoulder Innovations, a new entrant in… [Read More]

24 hours ago